Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Sales (2020 - 2025)

RxSight (RXST) has disclosed Return on Sales for 6 consecutive years, with 0.91% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 106.0% year-over-year to 0.91%, compared with a TTM value of 0.0% through Dec 2025, up 20.0%, and an annual FY2025 reading of 0.0%, up 20.0% over the prior year.
  • Return on Sales was 0.91% for Q4 2025 at RxSight, up from 0.32% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.91% in Q4 2025 and bottomed at 2.75% in Q2 2021.
  • Average Return on Sales over 5 years is 0.88%, with a median of 0.61% recorded in 2023.
  • Peak annual rise in Return on Sales hit 201bps in 2021, while the deepest fall reached -1954bps in 2021.
  • Year by year, Return on Sales stood at 1.87% in 2021, then soared by 48bps to 0.97% in 2022, then soared by 67bps to 0.32% in 2023, then skyrocketed by 54bps to 0.15% in 2024, then soared by 717bps to 0.91% in 2025.
  • Business Quant data shows Return on Sales for RXST at 0.91% in Q4 2025, 0.32% in Q3 2025, and 0.35% in Q2 2025.